• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Happiness Development Group Limited

    11/15/23 9:00:05 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HAPP alert in real time by email
    6-K 1 ea188318-6k_paranovus.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of November 2023

     

    PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED

    (Exact name of registrant as specified in its charter)

     

    No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City

    Fujian Province, People’s Republic of China

    +86-0599-782-8808

    (Address of Principal Executive Office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒       Form 40-F ☐

     

     

     

     

     

     

    Entry into Material Agreements

     

    On November 12, 2023, Paranovus Entertainment Technology Limited, (the “Company”) entered into a software development agreement (the “Development Agreement”) with Blueline Studios Inc. (“Blueline”), a company incorporated in Vancouver, Canada. Pursuant to the Development Agreement, Blueline shall be responsible for developing and delivering certain interactive game application (“Hollywood Sunshine”), including the underlying software, documentation, and technical data, under the terms and conditions of the Development Agreement, and agreed to assign to the Company all the right, title, and interest in Hollywood Sunshine, excluding any Background Technology (as defined in the Development Agreement). Blueline will deliver the initial full-featured version for the PC platform (the “PC Release”) six months after the Start Date as defined in the Development Agreement, followed by the delivery of iOS version (the “iOS Release”) three months after the PC Release. In exchange, the Company agreed to pay a total of $1,500,000 development fee to Blueline for the PC Release, and $400,000 development fee for the iOS Release, in accordance with the schedule set forth in the Development Agreement. The decision to develop the iOS Release is at the discretion of the Company. Furthermore, once Hollywood Sunshine starts generating revenues, the Company agreed to pay Blueline 9% of the net revenue after deducting all the licensing fees owned to all talent partners.

     

    On November 9, 2023, the Company signed a promissory note purchase agreement (the “Purchase Agreement”) with a non-U.S. investor (the “Investor”), pursuant to which, the Company issued an 8% promissory note with principal amount of $750,000 (the “Note”) to such Investor on November 14, 2023, the closing date of this transaction. The Note will mature in 12-month after its issuance and can be pre-paid in part or in whole by the Company prior to its maturity date. The proceeds from the Note will be used to fund the Hollywood Sunshine and the general corporate activities of the Company.

     

    The copies of the Development Agreement, Purchase Agreement and the Note are attached hereto as Exhibits 10.1, 10.2 and 10.3. The foregoing descriptions of the Development Agreement, Purchase Agreement and the Note are summaries of the material terms of such agreements, and do not purport to be complete and are qualified in their entirety by reference to the Development Agreement, Purchase Agreement and the Note.

     

    Exhibits

     

    Exhibit No.  Description
    10.1  The Software Development Agreement, dated November 12, 2023
    10.2  The Promissory Note Purchase Agreement, dated November 9, 2023
    10.3  The Promissory Note, dated November 14, 2023

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Paranovus Entertainment Technology Limited
         
    Date: November 15, 2023 By: /s/ Xuezhu Wang
      Name:  Xuezhu Wang
      Title: Chief Executive Officer

     

     

    2

     

    Get the next $HAPP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HAPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HAPP
    SEC Filings

    View All

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/23/24 4:15:34 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 5:25:25 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Happiness Development Group Limited Announces Name Change to Paranovus Entertainment Technology Ltd.

    NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p

    3/13/23 9:10:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2

    10/27/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Announces 1 for 20 Reverse Share Split

    NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o

    10/10/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Financials

    Live finance-specific insights

    View All

    Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

    NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service

    1/6/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Acquires Majority Ownership in Fujian Shennong

    NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a

    10/25/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

    NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo

    1/22/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:48:39 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:52:26 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care